Congress of Clinical Rheumatology West

Janet Pope, MD, professor of medicine at the University of Toronto, discusses whether she believes clinicians will ever transition away from DMARDs and biologics due to the high cost and what the alternatives are for those patients.

Elena Myasoedova, MD, of the Mayo Clinic, discusses the results of a study examining the incidence rates of cardiovascular disease in patients with rheumatoid arthritis across 3 decades.

Rania Al Asmar, MBBS, discusses a study she led and authored that examined prevalence and characteristics of patients with rheumatoid arthritis who later developed coronary artery disease.

Jack Stacy, MSIV, of University of North Dakota, discusses a study he co-authored and presented at CCR West examining the use of low-dose prednisone to induce remission in patients with rheumatoid arthritis.

Janet Pope, MD, a professor at the University of Toronto and CCR Faculty member, discusses what her biggest takeaways and highlights from the first day of CCR West in San Diego.

A cohort assessment of patients treated in a rural academic-based clinic finds just 10% of patients were vaccinated for the disease their RA therapies put them at more risk for.

In a small pilot study, investigators find medication non-adherence leads to more hospitalization of SLE patients.

A new study shows adherence to current ACR guidelines for therapy results in improved disease activity scores.

In new data presented at CCR West, investigators link smoking and ethnicity with organ damage of SLE patients.